You’re using a public version of DrugPatentWatch with 5 free searches available | Register to unlock more free searches. CREATE FREE ACCOUNT

Last Updated: March 29, 2024

SINEMET Drug Patent Profile


✉ Email this page to a colleague

« Back to Dashboard


Which patents cover Sinemet, and when can generic versions of Sinemet launch?

Sinemet is a drug marketed by Organon and Organon Llc and is included in two NDAs.

The generic ingredient in SINEMET is carbidopa; levodopa. There are eighteen drug master file entries for this compound. Thirty-three suppliers are listed for this compound. Additional details are available on the carbidopa; levodopa profile page.

DrugPatentWatch® Litigation and Generic Entry Outlook for Sinemet

A generic version of SINEMET was approved as carbidopa; levodopa by DR REDDYS LABS SA on August 28th, 1992.

  Try a Trial

Drug patent expirations by year for SINEMET
Drug Prices for SINEMET

See drug prices for SINEMET

Recent Clinical Trials for SINEMET

Identify potential brand extensions & 505(b)(2) entrants

SponsorPhase
University of California, Los AngelesPhase 1/Phase 2
Laboratorios Andromaco S.A.Phase 1
Northwestern Medical GroupPhase 2

See all SINEMET clinical trials

Pharmacology for SINEMET
Anatomical Therapeutic Chemical (ATC) Classes for SINEMET

US Patents and Regulatory Information for SINEMET

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Organon SINEMET carbidopa; levodopa TABLET;ORAL 017555-001 Approved Prior to Jan 1, 1982 AB RX Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Organon Llc SINEMET CR carbidopa; levodopa TABLET, EXTENDED RELEASE;ORAL 019856-002 Dec 24, 1992 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Organon SINEMET carbidopa; levodopa TABLET;ORAL 017555-003 Approved Prior to Jan 1, 1982 AB RX Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Organon SINEMET carbidopa; levodopa TABLET;ORAL 017555-002 Approved Prior to Jan 1, 1982 AB RX Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
Organon Llc SINEMET CR carbidopa; levodopa TABLET, EXTENDED RELEASE;ORAL 019856-001 May 30, 1991 DISCN Yes No ⤷  Try a Trial ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >TE >Type >RLD >RS >Patent No. >Patent Expiration >Product >Substance >Delist Req. >Exclusivity Expiration

Expired US Patents for SINEMET

Applicant Tradename Generic Name Dosage NDA Approval Date Patent No. Patent Expiration
Organon SINEMET carbidopa; levodopa TABLET;ORAL 017555-002 Approved Prior to Jan 1, 1982 ⤷  Try a Trial ⤷  Try a Trial
Organon SINEMET carbidopa; levodopa TABLET;ORAL 017555-002 Approved Prior to Jan 1, 1982 ⤷  Try a Trial ⤷  Try a Trial
Organon SINEMET carbidopa; levodopa TABLET;ORAL 017555-001 Approved Prior to Jan 1, 1982 ⤷  Try a Trial ⤷  Try a Trial
Organon SINEMET carbidopa; levodopa TABLET;ORAL 017555-003 Approved Prior to Jan 1, 1982 ⤷  Try a Trial ⤷  Try a Trial
Organon SINEMET carbidopa; levodopa TABLET;ORAL 017555-002 Approved Prior to Jan 1, 1982 ⤷  Try a Trial ⤷  Try a Trial
Organon SINEMET carbidopa; levodopa TABLET;ORAL 017555-003 Approved Prior to Jan 1, 1982 ⤷  Try a Trial ⤷  Try a Trial
>Applicant >Tradename >Generic Name >Dosage >NDA >Approval Date >Patent No. >Patent Expiration

EU/EMA Drug Approvals for SINEMET

Company Drugname Inn Product Number / Indication Status Generic Biosimilar Orphan Marketing Authorisation Marketing Refusal
Amneal Pharma Europe Ltd Numient levodopa, carbidopa EMEA/H/C/002611
Symptomatic treatment of adult patients with Parkinson’s disease
Withdrawn no no no 2015-11-19
>Company >Drugname >Inn >Product Number / Indication >Status >Generic >Biosimilar >Orphan >Marketing Authorisation >Marketing Refusal

International Patents for SINEMET

See the table below for patents covering SINEMET around the world.

Country Patent Number Title Estimated Expiration
Austria A490073 ⤷  Try a Trial
Czechoslovakia 178077 ⤷  Try a Trial
Canada 919691 PROCESS FOR PREPARING SUBSTITUTED PHENYLALKANOIC ACIDS AND INTERMEDIATES ⤷  Try a Trial
Romania 62503 ⤷  Try a Trial
Yugoslavia 35111 ⤷  Try a Trial
Switzerland 555810 VERFAHREN ZUR HERSTELLUNG VON L-ALPHA-HYDRAZINO-BETAPHENYLALKANSAEUREN, DEREN SALZEN ODER ESTERN. ⤷  Try a Trial
>Country >Patent Number >Title >Estimated Expiration

Make Better Decisions: Try a trial or see plans & pricing

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.